Fortfahren mit
Größe auswählen
| Größe/SKU | Verfügbarkeit | Preis |
|---|---|---|
30 mg | Warenkorb auf Verfügbarkeit prüfen | € 1.280,00 |
Über diesen Artikel
grade
pharmaceutical primary standard
agency
USP
API family
gabapentin
manufacturer/tradename
USP
application(s)
pharmaceutical
pharmaceutical (small molecule)
format
neat
SMILES string
OC(=O)CC1(CCCCC1)C#N
InChI
1S/C9H13NO2/c10-7-9(6-8(11)12)4-2-1-3-5-9/h1-6H2,(H,11,12)
InChI key
YGFXLCAKCKPSQQ-UHFFFAOYSA-N
General description
Analysis Note
Other Notes
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| description United States Pharmacopeia (USP) Reference Standard | description Pharmaceutical Secondary Standard; Certified Reference Material | description United States Pharmacopeia (USP) Reference Standard | description United States Pharmacopeia (USP) Reference Standard |
| manufacturer/tradename USP | manufacturer/tradename - | manufacturer/tradename USP | manufacturer/tradename USP |
| grade pharmaceutical primary standard | grade analytical standard, pharmaceutical secondary standard | grade pharmaceutical primary standard | grade pharmaceutical primary standard |
| format neat | format - | format neat | format neat |
| application(s) pharmaceutical (small molecule) | application(s) pharmaceutical | application(s) pharmaceutical (small molecule) | application(s) pharmaceutical (small molecule) |
| agency USP | agency traceable to Ph. Eur. Y0001348, traceable to USP 1287347 | agency USP | agency USP |
| API family gabapentin | API family gabapentin | API family gabapentin | API family gabapentin |
Still not finding the right product?
Explore all of our products under Gabapentin-verwandte Verbindung B
Signalwort
Warning
Gefahrencodes
Hazard Classifications
Acute Tox. 4 Oral - Aquatic Chronic 3
Lagerklasse
11 - Combustible Solids
Flammpunkt (°F)
Not applicable
Flammpunkt (°C)
Not applicable
Sicherheitshinweise
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.



